EPH receptors are a family of receptor tyrosine kinases that, together with their ligands, are involved in cell positioning, tissue and organ patterning as well as the control of cell survival. In their Review on page 39, Lackman and colleagues discuss EPH receptor–ephrin signalling and its role in disorders such as tumour growth and progression, nerve injury and inflammation, and highlight therapeutic approaches that are currently under investigation. Here in Table 1 we highlight patent applications published in the past 3 years related to EPH receptors and ligands. Data were researched using the Espacenet database.

Table 1 Recent patent applications related to EPH receptors and ligands
Full size table